These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
458 related items for PubMed ID: 7511575
1. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes. Yano S, Sone S, Nishioka Y, Naito M, Tsuruo T, Ogura T. Jpn J Cancer Res; 1994 Feb; 85(2):194-203. PubMed ID: 7511575 [Abstract] [Full Text] [Related]
2. Effector cell analysis of human multidrug-resistant cell killing by mouse-human chimeric antibody against P-glycoprotein. Nishioka Y, Sone S, Heike Y, Hamada H, Ariyoshi K, Tsuruo T, Ogura T. Jpn J Cancer Res; 1992 Jun; 83(6):644-9. PubMed ID: 1353755 [Abstract] [Full Text] [Related]
3. The role of cyclosporin A on antibody-dependent monocyte-mediated cytotoxicity against human multidrug-resistant cancer cells. Yano S, Yanagawa H, Hanibuchi M, Pai K, Nishioka Y, Tsuruo T, Sone S. J Med Invest; 1998 Feb; 44(3-4):185-91. PubMed ID: 9597807 [Abstract] [Full Text] [Related]
4. Monoclonal anti-P-glycoprotein antibody-dependent killing of multidrug-resistant tumor cells by human mononuclear cells. Heike Y, Hamada H, Inamura N, Sone S, Ogura T, Tsuruo T. Jpn J Cancer Res; 1990 Nov; 81(11):1155-61. PubMed ID: 1979977 [Abstract] [Full Text] [Related]
5. M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophage-mediated cytotoxicity. Heike Y, Sone S, Yano S, Seimiya H, Tsuruo T, Ogura T. Int J Cancer; 1993 Jul 09; 54(5):851-7. PubMed ID: 8100809 [Abstract] [Full Text] [Related]
6. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA. Dietel M, Herzig I, Reymann A, Brandt I, Schaefer B, Bunge A, Heidebrecht HJ, Seidel A. J Cancer Res Clin Oncol; 1994 Jul 09; 120(5):263-71. PubMed ID: 7907333 [Abstract] [Full Text] [Related]
8. Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes. Hanibuchi M, Yano S, Nishioka Y, Yanagawa H, Sone S. Jpn J Cancer Res; 1996 May 09; 87(5):497-504. PubMed ID: 8641987 [Abstract] [Full Text] [Related]
13. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for cyclosporine. Ryffel B, Woerly G, Rodriguez C, Foxwell BM. J Recept Res; 1991 May 09; 11(1-4):675-86. PubMed ID: 1679456 [Abstract] [Full Text] [Related]
14. P-glycoprotein-mediated multidrug resistance and lymphokine-activated killer cell susceptibility in ovarian carcinoma. Savas B, Cole SP, Tsuruo T, Pross HF. J Clin Immunol; 1996 Nov 09; 16(6):348-57. PubMed ID: 8946280 [Abstract] [Full Text] [Related]
15. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH. Zacherl J, Hamilton G, Thalhammer T, Riegler M, Cosentini EP, Ellinger A, Bischof G, Schweitzer M, Teleky B, Koperna T. Cancer Chemother Pharmacol; 1994 Nov 09; 34(2):125-32. PubMed ID: 7910786 [Abstract] [Full Text] [Related]
19. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance. Naito M, Tsuge H, Kuroko C, Koyama T, Tomida A, Tatsuta T, Heike Y, Tsuruo T. J Natl Cancer Inst; 1993 Feb 17; 85(4):311-6. PubMed ID: 7678867 [Abstract] [Full Text] [Related]
20. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A. Flieger D, Spengler U, Beier I, Sauerbruch T, Schmidt-Wolf IG. Z Gastroenterol; 2000 Aug 17; 38(8):615-22. PubMed ID: 11031784 [Abstract] [Full Text] [Related] Page: [Next] [New Search]